Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
Rishi Naik MD, MSCI

Rishi Naik MD, MSCI

Assistant Professor of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee

Rishi Naik is an Assistant Professor of Medicine at Vanderbilt University Medical Center. He graduated Alpha Omega Alpha from Vanderbilt Medical School, completed internship and residency at Vanderbilt, and was selected as Vanderbilt’s chief fellow for his gastroenterology fellowship. He completed the Master in Science and Clinical Investigation (MSCI) program, which has provided a framework for enhancing clinical research and better patient care. He serves on the Board of Editors for Gastroenterology and is funded by the NIH for novel management of achalasia. In addition to his role as an esophagologist with expertise in mucosal diseases (eosinophilic esophagitis) and motor diseases (achalasia, absent contractility), he is the director of fecal transplant at Vanderbilt University Medical center.

Education

MD - Vanderbilt University School of Medicine - 2013

Internship - Internal Medicine - Vanderbilt University Medical Center - 2014

Residency - Internal Medicine - Vanderbilt University Medical Center - 2016

MSCI - Vanderbilt University - 2019

Fellowship - Gastroenterology, Hepatology, Nutrition - Vanderbilt University Medical Center - 2019

Disclosures

Dr. Naik has no relevant disclosures.

Recent Contributions to PracticeUpdate:

  1. Helicobacter pylori Eradication for Primary Prevention of Aspirin-Associated Peptic Ulcer Bleeding in Older Patients

Most Read This Week

Recently Updated